Skip to main content
editor.ajphr@gmail.com
9409046853
e-ISSN: 2321-3647
American Journal of Pharmacy and Health Research

American Journal of Pharmacy and Health Research

Published

Synthesized Dendritic Macromolecule Improve the Solubility of Enzalutamide

Published in December 2023 Issue 12 (Vol. 11, Issue 12, 2023)

Synthesized Dendritic Macromolecule Improve the Solubility of Enzalutamide - Issue cover

Abstract

ABSTRACTProstate cancer is an androgen-dependent disease that responds to established therapies that reduce circulating testosterone levels or inhibit androgen binding to the androgen receptor. This has resulted in the development of a variety of new drugs that target this hormone-regulated transcription factor. Oral enzalutamide drug is a potent androgen receptor antagonist inhibitor for the treatment of castration-resistant prostate cancer, but enzalutamide is classified as BCS class II substances with low aqueous solubility. In recent decades, dendrimers have proven to be effective as solubilizers. Due to their special qualities, dendritic macromolecule is an effective drug solubilizing agent. Therefor the current work is to improve the solubility of enzalutamide by using hydroxy-terminated dendritic macromolecules. The potential of nanoscale hydroxy-terminated dendritic macromolecules TG1.0, TG2.0 and TG3.0 as enzalutamide solubility enhancers was investigated. The effect of concentration and generation of synthesized dendritic macromolecules on enzalutamide solubility was investigated. The FT-IR spectra were used to characterize the formation of complexes between drug molecules and dendritic macromolecules. The experimental results revealed that enzalutamide solubility increased with dendrimer concentration and generation. The cytotoxicity and hemolytic potential of synthesized hydroxy-terminated dendritic macromolecules excelled over commercially available polyamidoamine dendrimers (PAMAM) in a cytotoxicity assay using A-549 lung cancer cell lines. Keywords: Enzalutamide, Cytotoxicity, Dendrimer, Hemolysis, Solubility

Citations & discovery

Explore citations to this article and find it in scholarly databases.

Crossref
…
Citations
View record
Europe PMC
…
DOI matches
View results
Google Scholar

Checking citation sources…

Citation counts reflect each source's coverage. Europe PMC shows DOI search matches, including mentions in references. Article lists may be incomplete. Google Scholar opens a separate search.

Authors (4)

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Summarise this paper with AI:

Article Information

AJPHR1112002

AJPHR-01-000867

1-16

2023-12-01

JATS XML

Article Impact

Views:3,684
Downloads:1,492
scite_
PlumX Metrics Badge

How to Cite

Patel, V., Patel, P., Patel, P. M., & Patel, J. V. (2023). Synthesized Dendritic Macromolecule Improve the Solubility of Enzalutamide. American Journal of Pharmacy and Health Research, 11(12), 1-16. https://doi.org/10.5281/zenodo.10526296

Article Actions

Whatsapp